Jodi M. Carter, M.D., Ph.D.

  1. Pathologist

Publications

  1. Kohale IN, Burgenske DM, Mladek AC, Bakken KK, Kuang J, Boughey JC, Wang L, Carter JM, Haura EB, Goetz MP, Sarkaria JN, White FM. Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks. Cancer Res. 2021 Jul 15; 81 (14):3930-3941 Epub 2021 May 20
    View PubMed
  2. He Y, Wang L, Wei T, Xiao YT, Sheng H, Su H, Hollern DP, Zhang X, Ma J, Wen S, Xie H, Yan Y, Pan Y, Hou X, Tang X, Suman VJ, Carter JM, Weinshilboum R, Wang L, Kalari KR, Weroha SJ, Bryce AH, Boughey JC, Dong H, Perou CM, Ye D, Goetz MP, Ren S, Huang H. FOXA1 overexpression suppresses interferon signaling and immune response in cancer. J Clin Invest. 2021 Jul 15; 131 (14)
    View PubMed
  3. Winham SJ, Wang C, Heinzen EP, Bhagwate A, Liu Y, McDonough SJ, Stallings-Mann ML, Frost MH, Vierkant RA, Denison LA, Carter JM, Sherman ME, Radisky DC, Degnim AC, Cunningham JM. Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC Med Genomics. 2021 Jul 14; 14 (1):185 Epub 2021 July 14
    View PubMed
  4. Geiersbach KB, Sill DR, Meyer RG, Yuhas JA, Sukov WR, Mounajjed T, Carter JM, Jenkins RB, Chen B. HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ Hybridization. Arch Pathol Lab Med. 2021 Jul 1; 145 (7):883-886
    View PubMed
  5. Carter JM, Polley MC, Leon-Ferre RA, Sinnwell J, Thompson KJ, Wang X, Ma Y, Zahrieh D, Kachergus JM, Solanki M, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Thompson EA, Goetz MP. Characteristics and spatially-defined immune (micro)landscapes of early-stage PD-L1-positive triple-negative breast cancer. Clin Cancer Res. 2021 Jun 9 Epub 2021 June 09
    View PubMed
  6. Boughey JC, Suman VJ, Yu J, Santo K, Sinnwell JP, Carter JM, Kalari KR, Tang X, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Hunt KN, Conners AL, Ingle JN, Moyer A, Weinshilboum R, Copland JA 3rd, Wang L, Goetz MP. Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY). Clin Cancer Res. 2021 Jun 2 Epub 2021 June 02
    View PubMed
  7. Du L, Yau C, Brown-Swigart L, Gould R, Krings G, Hirst GL, Bedrosian I, Layman RM, Carter JM, Klein M, Venters S, Shad S, van der Noordaa M, Chien AJ, Haddad T, Isaacs C, Pusztai L, Albain K, Nanda R, Tripathy D, Liu MC, Boughey J, Schwab R, Hylton N, DeMichele A, Perlmutter J, Yee D, Berry D, Van't Veer L, Valero V, Esserman LJ, Symmans WF. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy. Ann Oncol. 2021 May; 32 (5):642-651 Epub 2021 Feb 19
    View PubMed
  8. Everson MC, Pendleton C, Jack MM, Smith BW, Carter JM, Spinner RJ. Sporadic Malignant Perineurioma: A Rare Diagnosis Among Malignant Peripheral Nerve Sheath Tumors. World Neurosurg. 2021 May; 149:e36-e41 Epub 2021 Feb 27
    View PubMed
  9. Gu J, Polley EC, Denis M, Carter JM, Pruthi S, Gregory AV, Boughey JC, Fazzio RT, Fatemi M, Alizad A. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer. Breast Cancer Res. 2021 Apr 29; 23 (1):52
    View PubMed
  10. Jalalirad M, Haddad TC, Salisbury JL, Radisky D, Zhang M, Schroeder M, Tuma A, Leof E, Carter JM, Degnim AC, Boughey JC, Sarkaria J, Yu J, Wang L, Liu MC, Zammataro L, Malatino L, Galanis E, Ingle JN, Goetz MP, D'Assoro AB. Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance. Oncogene. 2021 Apr; 40 (14):2509-2523 Epub 2021 Mar 05
    View PubMed
  11. Carter JM, Maldonado AA, Howe BM, Okuno S, Spinner RJ. Frequent CTNNB1 p.S45 Mutations and Aggressive Clinical Behavior in Neuromuscular Choristoma-Associated Fibromatosis. Neurosurgery. 2021 Mar 15; 88 (4):804-811
    View PubMed
  12. Marek T, Mahan MA, Carter JM, Howe BM, Bartos R, Amrami KK, Spinner RJ. What's known and what's new in adipose lesions of peripheral nerves? Acta Neurochir (Wien). 2021 Mar; 163 (3):835-842 Epub 2020 Oct 22
    View PubMed
  13. Polley MC, Leon-Ferre RA, Leung S, Cheng A, Gao D, Sinnwell J, Liu H, Hillman DW, Eyman-Casey A, Gilbert JA, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari K, Couch F, Carter JM, Visscher DW, Nielsen TO, Goetz MP. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer. Breast Cancer Res Treat. 2021 Feb; 185 (3):557-566 Epub 2021 Jan 03
    View PubMed
  14. Limberg AK, Tibbo ME, Salib CG, McLaury AR, Turner TW, Berry CE, Jay AG, Carter JM, Bolon B, Berry DJ, Morrey ME, Sanchez-Sotelo J, van Wijnen AJ, Abdel MP. Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen. J Orthop Res. 2020 Nov; 38 (11):2474-2483 Epub 2020 Mar 11
    View PubMed
  15. Sherman ME, Vierkant RA, Kaggal S, Hoskin TL, Frost MH, Denison L, Visscher DW, Carter JM, Winham SJ, Jensen MR, Radisky DC, Vachon CM, Degnim AC. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prev Res (Phila). 2020 Nov; 13 (11):967-976 Epub 2020 July 27
    View PubMed
  16. Marek T, Mahan MA, Amrami KK, Blackburn PR, Caffes PL, Carter JM, Camilleri M, Spinner RJ. Expanding the phenotypic spectrum of lipomatosis of the sciatic nerve: Early-onset colonic diverticular disease. Neurogastroenterol Motil. 2020 Oct; 32 (10):e13917 Epub 2020 June 21
    View PubMed
  17. Tibbo ME, Limberg AK, Salib CG, Turner TW, McLaury AR, Jay AG, Bettencourt JW, Carter JM, Bolon B, Berry DJ, Morrey ME, Sanchez-Sotelo J, van Wijnen AJ, Abdel MP. Anti-fibrotic effects of the antihistamine ketotifen in a rabbit model of arthrofibrosis. Bone Joint Res. 2020 Jun; 9 (6):302-310 Epub 2020 July 23
    View PubMed
  18. Jayaraman S, Hou X, Kuffel MJ, Suman VJ, Hoskin TL, Reinicke KE, Monroe DG, Kalari KR, Tang X, Zeldenrust MA, Cheng J, Bruinsma ES, Buhrow SA, McGovern RM, Safgren SL, Walden CA, Carter JM, Reid JM, Ingle JN, Ames MM, Hawse JR, Goetz MP. Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer. Breast Cancer Res. 2020 May 19; 22 (1):51
    View PubMed
  19. Maldonado AA, Spinner RJ, Broski SM, Stone JJ, Howe BM, Carter JM. Neuromuscular choristoma-associated desmoid-type fibromatosis: Establishing a nerve territory concept. Acta Neurochir (Wien). 2020 May; 162 (5):1137-1146 Epub 2020 Jan 02
    View PubMed
  20. Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M, International Immuno-Oncology Biomarker Working Group. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. J Pathol. 2020 Apr; 250 (5):667-684 Epub 2020 Apr 09
    View PubMed
  21. Blackburn PR, Milosevic D, Marek T, Folpe AL, Howe BM, Spinner RJ, Carter JM. PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth. Mod Pathol. 2020 Mar; 33 (3):420-430 Epub 2019 Sept 03
    View PubMed
  22. Norton N, Youssef B, Hillman DW, Nassar A, Geiger XJ, Necela BM, Liu H, Ruddy KJ, Polley MC, Ingle JN, Couch FJ, Perez EA, Liu MC, Carter JM, Leon-Ferre RA, Boughey JC, Somers EB, Kalari KR, Visscher DW, Goetz MP, Knutson KL. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients. NPJ Breast Cancer. 2020 Feb 4; 6 (1):4 Epub 2020 Feb 04
    View PubMed
  23. Hawse JR, Carter JM, Aspros KGM, Bruinsma ES, Koepplin JW, Negron V, Subramaniam M, Ingle JN, Rech KL, Goetz MP. Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues. Breast Cancer Res Treat. 2020 Jan; 179 (1):241-249 Epub 2019 Sept 30
    View PubMed
  24. Norton N, Youssef B, Hillman DW, Nassar A, Geiger XJ, Necela BM, Liu H, Ruddy KJ, Polley MC, Ingle JN, Couch FJ, Perez EA, Liu MC, Carter JM, Leon-Ferre RA, Boughey JC, Somers EB, Kalari KR, Visscher DW, Goetz MP, Knutson KL. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients. NPJ Breast Cancer. 2020; 6:4 Epub 2020 Feb 04
    View PubMed
  25. Ren Y, Cherukuri Y, Wickland DP, Sarangi V, Tian S, Carter JM, Mansfield AS, Block MS, Sherman ME, Knutson KL, Lin Y, Asmann YW. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer. Oncoimmunology. 2020; 9 (1):1744947 Epub 2020 Apr 01
    View PubMed
  26. Salib CG, Reina N, Trousdale WH, Limberg AK, Tibbo ME, Jay AG, Robin JX, Turner TW, Jones CR, Paradise CR, Lewallen EA, Bolon B, Carter JM, Berry DJ, Morrey ME, Sanchez-Sotelo J, van Wijnen AJ, Abdel MP. Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture. J Orthop Res. 2019 Dec; 37 (12):2609-2620 Epub 2019 Aug 26
    View PubMed
  27. Hunt KN, Conners AL, Goetz MP, O'Connor MK, Suman V, Kalari K, Weinshilboum R, Wang L, Carter J, McLaughlin S, Aspitia AM, Gray R, Northfelt D, Boughey JC. Comparison of (99m)Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy. AJR Am J Roentgenol. 2019 Oct; 213 (4):932-943 Epub 2019 June 05
    View PubMed
  28. Bhagwate AV, Liu Y, Winham SJ, McDonough SJ, Stallings-Mann ML, Heinzen EP, Davila JI, Vierkant RA, Hoskin TL, Frost M, Carter JM, Radisky DC, Cunningham JM, Degnim AC, Wang C. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples. BMC Genomics. 2019 Sep 2; 20 (1):689 Epub 2019 Sept 02
    View PubMed
  29. Dashti NK, Howe BM, Inwards CY, Fritchie KJ, Carter JM. High-grade squamous cell carcinoma arising in a tibial adamantinoma. Hum Pathol. 2019 Sep; 91:123-128 Epub 2018 Nov 26
    View PubMed
  30. Marek T, Mahan MA, Carter JM, Amrami KK, Atkinson JLD, Spinner RJ. Can Lipomatosis of the Nerve Occur or Extend Intradurally? World Neurosurg. 2019 Sep; 129:e555-e560 Epub 2019 May 30
    View PubMed
  31. Maldonado AA, Spinner RJ, Carter JM, Stone JJ, Howe BM. Clinical and Magnetic Resonance Imaging Longitudinal Follow-up of Neuromuscular Choristomas. World Neurosurg. 2019 Sep; 129:e761-e766 Epub 2019 June 13
    View PubMed
  32. Marek T, Mahan MA, Carter JM, Amrami KK, Benarroch EE, Spinner RJ. Lipomatosis of nerve and overgrowth: is there a preference for motor (mixed) vs. sensory nerve involvement? Acta Neurochir (Wien). 2019 Apr; 161 (4):679-684 Epub 2019 Feb 23
    View PubMed
  33. Stone JJ, Amrami KK, Carter JM, Spinner RJ. Stimulation Contractility Gradient of a Neuromuscular Choristoma Within the Sciatic Nerve: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2019 Jan 1; 16 (1):E17
    View PubMed
  34. Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, I-SPY2 Investigators. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2019; 5:2 Epub 2019 Jan 02
    View PubMed
  35. Samreen N, Lee C, Bhatt A, Carter J, Hieken T, Adler K, Zingula S, Glazebrook KN. A Clinical Approach to Diffusion-Weighted Magnetic Resonance Imaging in Evaluating Chest Wall Invasion of Breast Tumors. J Clin Imaging Sci. 2019; 9:11 Epub 2019 Apr 30
    View PubMed
  36. Carter JM, Wu Y, Blessing MM, Folpe AL, Thorland EC, Spinner RJ, Jentoft ME, Wang C, Baheti S, Niu Z, Mauermann ML, Klein CJ. Recurrent Genomic Alterations in Soft Tissue Perineuriomas. Am J Surg Pathol. 2018 Dec; 42 (12):1708-1714
    View PubMed
  37. Mueller K, Kokotilo MS, Carter JM, Thiesen A, Madsen KL, Studzinski J, Khadaroo RG, Churchill TA. Creatine-loading preserves intestinal barrier function during organ preservation. Cryobiology. 2018 Oct; 84:69-76 Epub 2018 Aug 01
    View PubMed
  38. Stone JJ, Prasad NK, Laumonerie P, Howe BM, Amrami KK, Carter JM, Jentoft ME, Spinner RJ. Recurrent desmoid-type fibromatosis associated with underlying neuromuscular choristoma. J Neurosurg. 2018 Aug 31; 131 (1):175-183
    View PubMed
  39. Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. J Clin Oncol. 2018 Jun 20; 36 (18):1840-1846 Epub 2018 Apr 20
    View PubMed
  40. Broehm CJ, Inwards CY, Al-Ibraheemi A, Wenger DE, Jenkins SM, Jin L, Oliveira AM, Zreik RT, Carter JM, Boland JM, Fritchie KJ. Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 Patients. Am J Clin Pathol. 2018 Feb 17; 149 (3):222-233
    View PubMed
  41. Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC. CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes. Breast Cancer Res Treat. 2018 Feb; 167 (3):649-658 Epub 2017 Nov 01
    View PubMed
  42. Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC. Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease. Cancer Prev Res (Phila). 2018 Feb; 11 (2):113-119 Epub 2017 Nov 22
    View PubMed
  43. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ, and I-SPY 2 Investigators. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26 Epub 2018 Aug 17
    View PubMed
  44. Schoolmeester JK, Moyer AM, Goodenberger ML, Keeney GL, Carter JM, Bakkum-Gamez JN. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2. Hum Pathol. 2017 Dec; 70:14-26 Epub 2017 July 12
    View PubMed
  45. Knight JA, Hunt KN, Carter J. Nodular fasciitis of the breast in an elderly woman. Radiol Case Rep. 2017 Dec; 12 (4):642-644 Epub 2017 Aug 12
    View PubMed
  46. Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies. J Natl Cancer Inst. 2017 Oct 01; 109(10).
    View PubMed
  47. Glorioso JM, Gonzalez Juarrero AB, Rodysill BR, Harmsen WS, Habermann EB, Carter JM, Mutter RW, Degnim AC, Jakub JW. Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant Radiotherapy. Ann Surg Oncol. 2017 Oct; 24 (11):3148-3156 Epub 2017 July 05
    View PubMed
  48. Racz JM, Carter JM, Degnim AC. Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations. Ann Surg Oncol. 2017 Oct; 24 (10):2848-2854 Epub 2017 Aug 01
    View PubMed
  49. Racz JM, Carter JM, Degnim AC. Challenging Atypical Breast Lesions Including Flat Epithelial Atypia, Radial Scar, and Intraductal Papilloma. Ann Surg Oncol. 2017 Oct; 24 (10):2842-2847 Epub 2017 Aug 01
    View PubMed
  50. Olsen DL, Keeney GL, Chen B, Visscher DW, Carter JM. Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases. Hum Pathol. 2017 Sep; 67:94-100 Epub 2017 July 22
    View PubMed
  51. Carter JM, Howe BM, Inwards CY. Conditions Simulating Primary Bone Neoplasms. Surg Pathol Clin. 2017 Sep; 10 (3):731-748
    View PubMed
  52. Littrell LA, Carter JM, Broski SM, Wenger DE. Extra-adrenal myelolipoma and extramedullary hematopoiesis: Imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma. Eur J Radiol. 2017 Aug; 93:185-194 Epub 2017 May 29
    View PubMed
  53. Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development. Clin Cancer Res. 2017 Jul 15; 23 (14):3945-3952 Epub 2017 Jan 26
    View PubMed
  54. Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients. Breast Cancer Res. 2017 Jan 19; 19 (1):8
    View PubMed
  55. Carter JM, Wenger DE, Rose PS, Inwards CY. Atypical Notochordal Cell Tumors: A Series of Notochordal-derived Tumors That Defy Current Classification Schemes. Am J Surg Pathol. 2017 Jan; 41 (1):39-48
    View PubMed
  56. Al-Ibraheemi A, Inwards CY, Zreik RT, Wenger DE, Jenkins SM, Carter JM, Boland JM, Rose PS, Jin L, Oliveira AM, Fritchie KJ. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients. Am J Surg Pathol. 2016 Dec; 40 (12):1702-1712
    View PubMed
  57. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Carter JM, Glazebrook KN, Hieken TJ. Contemporary operative management of T4 breast cancer. Surgery. 2016 Oct; 160 (4):1059-1069 Epub 2016 Aug 09
    View PubMed
  58. Carter JM, Howe BM, Hawse JR, Giannini C, Spinner RJ, Fritchie KJ. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis. Am J Surg Pathol. 2016 Oct; 40 (10):1368-74
    View PubMed
  59. Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer. 2016 Oct; 122 (19):2971-8 Epub 2016 June 28
    View PubMed
  60. Frisch CD, Inwards CY, Lalich IJ, Carter JM, Neff BA. Atypical cartilaginous tumor/chondrosarcoma, grade 1, of the mastoid in three family members: A new entity. Laryngoscope. 2016 Sep; 126 (9):E310-3 Epub 2015 Dec 15
    View PubMed
  61. Carter JM, Wang X, Dong J, Westendorf J, Chou MM, Oliveira AM. USP6 genetic rearrangements in cellular fibroma of tendon sheath. Mod Pathol. 2016 Aug; 29 (8):865-9 Epub 2016 Apr 29
    View PubMed
  62. Zreik RT, Carter JM, Sukov WR, Ahrens WA, Fritchie KJ, Montgomery EA, Weiss SW, Folpe AL. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study. Hum Pathol. 2016 Jul; 53:14-24 Epub 2016 Mar 02
    View PubMed
  63. Carter JM, Erickson LA. An Adult Male With Hypophosphatemic Osteomalacia. Mayo Clin Proc. 2016 Jun; 91 (6):e81-2
    View PubMed
  64. Hieken TJ, Carter JM, Hawse JR, Hoskin TL, Bois M, Frost M, Hartmann LC, Radisky DC, Visscher DW, Degnim AC. ERbeta expression and breast cancer risk prediction for women with atypias. Cancer Prev Res (Phila). 2015 Nov; 8 (11):1084-92 Epub 2015 Aug 14
    View PubMed
  65. Landercasper J, Attai D, Atisha D, Beitsch P, Bosserman L, Boughey J, Carter J, Edge S, Feldman S, Froman J, Greenberg C, Kaufman C, Morrow M, Pockaj B, Silverstein M, Solin L, Staley A, Vicini F, Wilke L, Yang W, Cody H III. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: The American Society of Breast Surgeons consensus conference. Ann Surg Oncol. 2015 Oct; 22(10):3174-83.
    View PubMed
  66. Sandell RF, Carter JM, Folpe AL. Solitary (juvenile) xanthogranuloma: a comprehensive immunohistochemical study emphasizing recently developed markers of histiocytic lineage. Hum Pathol. 2015 Sep; 46(9):1390-7. Epub 2015 Jun 10.
    View PubMed
  67. Romano RC, Carter JM, Folpe AL. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases. Mod Pathol. 2015 Aug; 28 (8):1033-42 Epub 2015 May 29
    View PubMed
  68. Lee JC, Jeng YM, Su SY, Wu CT, Tsai KS, Lee CH, Lin CY, Carter JM, Huang JW, Chen SH, Shih SR, Marino-Enriquez A, Chen CC, Folpe AL, Chang YL, Liang CW. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 2015; 235(4):539-45.
    View PubMed
  69. Carter JM, Caron BL, Dogan A, Folpe AL. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol. 2015 Jan; 39 (1):75-83
    View PubMed
  70. Linos K, Carter JM, Gardner JM, Folpe AL, Weiss SW, Edgar MA. Myofibromas with atypical features: expanding the morphologic spectrum of a benign entity. Am J Surg Pathol. 2014 Dec; 38(12):1649-54.
    View PubMed
  71. Carter JM, Sukov WR, Montgomery E, Goldblum JR, Billings SD, Fritchie KJ, Folpe AL. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms. Am J Surg Pathol. 2014 Sep; 38 (9):1182-992
    View PubMed
  72. Carter JM, Inwards CY, Jin L, Evers B, Wenger DE, Oliveira AM, Fritchie KJ. Activating GNAS mutations in parosteal osteosarcoma. Am J Surg Pathol. 2014 Mar; 38: (3)402-9.
    View PubMed
  73. Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol. 2014 Feb; 27(2):294-302. Epub 2013 Jul 26
    View PubMed
  74. Carter JM, Inwards CY. Conventional chondrosarcoma: Old controversies and new insights. Diagn Histopathol. 2014; 20(5):181-9.
  75. Carter JM, O'Hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, Judkins AR, Biegel JA, Folpe AL. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol. 2012 Jan; 36: (1)154-60.
    View PubMed
  76. Schlachter K, Kokotilo MS, Carter J, Thiesen A, Ochs A, Khadaroo RG, TA, Churchill. Redefining the properties of an osmotic agent in an intestinal-specific preservation solution. World J Gastroenterol. 2010; 16:5701-9.
  77. Kokotilo MS, Carter J, Thiesen A, Chen MH, Ochs A, Khadaroo RG, TA, Churchill. Optimizing the concentration of hydroxyethylstarch in a novel intestinal-specific preservation solution. Cryobiology. 2010; 61:236-42.
  78. Kokotilo MS, Schlachter K, Carter J, Thiesen A, Khadaroo RG, TA, Churchill. Comparing the effects of Dextran 70 and Hydroxyethyl starch in an intestinal storage solution. Cryobiology. 2010; 61:254-62.
  79. Carter JM, Demizieux L, Campenot RB, Vance DE, Vance JE. Phosphatidylcholine biosynthesis via CTP:phosphocholine cytidylyltransferase 2 facilitates neurite outgrowth and branching. J Biol Chem. 2008 Jan 04; 283: (1)202-12.
    View PubMed
  80. Carter JM, Waite KA, Campenot RB, Vance JE, Vance DE. Enhanced expression and activation of CTP:phosphocholine cytidylyltransferase beta2 during neurite outgrowth. J Biol Chem. 2003 Nov 07; 278: (45)44988-94.
    View PubMed
  81. Sparrow SM, Carter JM, Ridgway ND, Cook HW, Byers DM. U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells. Neurochem Res. 1999 Jan; 24: (1)69-77.
    View PubMed
  82. Meinertzhagen IA, Govind CK, Stewart BA, Carter JM, Atwood HL. Regulated spacing of synapses and presynaptic active zones at larval neuromuscular junctions in different genotypes of the flies Drosophila and Sarcophaga. J Comp Neurol. 1998 Apr 20; 393: (4)482-92.
    View PubMed
PST-20216121